Advertisement
Om Manchanda
Premium
Healthcare
30 October, 2020
Sector watch: Will COVID-19 strengthen big diagnostics firms, spur consolidation?
When Nalanda Capital bet on Thyrocare Technologies Ltd in March, the private equity-style investor in public equities was likely enticed ......
Premium
Healthcare
08 April, 2019
Dr Lal PathLabs CEO on acquisition plans and declining PE interest in diagnostics
Dr Lal PathLabs Ltd, which became the first Indian diagnostics chain to list on the stock exchanges in 2015, has ......
Premium
Finance
05 April, 2018
Fund Scan: TA Associates' ‘no-experiment' approach pays off in India
The best guests are those who don’t disturb their hosts. And who don’t overstay their welcome. That, in a nutshell, ......
Advertisement
Recommended for you
Advertisement